NCT05529745

Brief Summary

Depending on their localization, cerebellar lesions cause various pronounced cognitive and/or affective dysfunctions, which are causally related to the involvement of cerebellar structures in neuronal networks for higher-order processing of cognitive and emotional items in the association areas of the cerebral cortex. For further investigation, event-related potential (ERP) analyses will be performed to record and visualize specific signals in the surface EEG, which should provide information about the course of treatment of neurorehabilitation with respect to a close correlation and thus predictive power to functional recovery that occurred as a result of cerebellar injury. With EEG parameters and clinical examination findings including neuropsychology, the functions for four thematically distributed domains (affective: prosody; cognitive: abstraction, linguistic and formal incongruence) will be recorded and evaluated over a four-week structured neurorehabilitation with an average therapy volume.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
13mo left

Started Jun 2023

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Jun 2023May 2027

First Submitted

Initial submission to the registry

August 26, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 7, 2022

Completed
9 months until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2027

Last Updated

September 7, 2022

Status Verified

August 1, 2022

Enrollment Period

3.1 years

First QC Date

August 26, 2022

Last Update Submit

September 2, 2022

Conditions

Keywords

Cerebellum - cognitive functions - neurorehabilitation

Outcome Measures

Primary Outcomes (1)

  • Changes of attentional and executive functioning in active group.

    Beneficial changes in attentional and executive function performance in ischemic cerebellar injury after structured neurorehabilitation modules. Measurements will be succeed by the Cerebellar Cognitive Affective/ Schmahmann Syndrome Scale (German version) with a maximum of 120 of 120 points, i.e. an increase of the test performance with higher point values along the neurorehabilitation procedure is considered as an indication of clinical improvement.

    26 weeks

Secondary Outcomes (1)

  • Extension of daily activities and life quality.

    52 weeks

Study Arms (2)

Treatment in cerebellar lesioned patient

EXPERIMENTAL

Group of patients with a lesion of the cerebellum gaining a neurorehabilitation intervention

Other: Neurorehabilitation cerebellar cognitive disorder

Treatment in supratentorial lesioned patient

ACTIVE COMPARATOR

Group of patients with a lesion of the supratentorial area gaining a neurorehabilitation intervention

Other: Neurorehabilitation cerebellar cognitive disorder

Interventions

Influence of neurorehabilitation treatment lines of physiotherapy and exercise therapy including scheduled occupational therapy to adapt and improve cognitive-affective disorders in cerebellar lesions.

Treatment in cerebellar lesioned patientTreatment in supratentorial lesioned patient

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • active group: patients with a cerebrovascular lesion within the cerebellum
  • comparator group: patients with a cerebrovascular lesion supratentorial

You may not qualify if:

  • any kind of history in neurological or psychiatric disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Wounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Michael Adamaszek, head of Dept. Clinical and Cognitive Neurorehabilitation

Study Record Dates

First Submitted

August 26, 2022

First Posted

September 7, 2022

Study Start

June 1, 2023

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

May 31, 2027

Last Updated

September 7, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share